Introduction The widespread use of antiretroviral therapies (ART) has increased life
expectancy in HIV patients, predisposing them to chronic non-communicable diseases …

Renal disease is becoming an increasingly prevalent entity in human immunodeficiency
virus (HIV)—infected patients; it occurs in a variety of clinical settings and is associated with …

Background: Tenofovir alafenamide (TAF) is a novel tenofovir prodrug with improved renal
and bone safety compared with TDF-containing regimens. We report the 48 week safety and …

Background: Reductions in AIDS-related morbidity and mortality following the advent of
combination antiretroviral therapy have coincided with relative increases in chronic non …

Background. Little is known about the racial differences in the incidence and progression of
HIV-related chronic kidney disease (CKD) that underlie African American—white disparities …

Background: Kidney disease is an increasingly important complication of HIV. Objectives: To
examine the incidence and predictors of acute renal failure before and after the introduction …

Kidney disease is an important complication of HIV, particularly in minority populations. We
describe the burden of chronic kidney disease among 1239 adults followed at an urban …

Increased reports of mumps in vaccinated populations prompted a review of the
performance of mumps vaccines. The effectiveness of prior vaccination with 1 dose of …

Chronic kidney disease (CKD) is a comorbidity of major clinical significance amongst people
living with HIV (PLWHIV) and is associated with significant morbidity and mortality. The …

Antiretroviral therapy (ART) has significantly improved life expectancy of infected subjects,
generating a new epidemiological setting of people aging withHuman Immunodeficiency …